Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.5B | 25.3B | 22.2B | 21.8B |
Cost of revenue | 17.9B | 20.0B | 18.5B | 18.0B |
Gross profit | 3.7B | 5.3B | 3.7B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.0B | 2.3B | 1.7B | 1.9B |
Operating income | 1.7B | 2.9B | 2.0B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 222M | 229M | 230M | 212M |
Other income expense | 79M | -570M | 155M | 137M |
Pretax income | 1.5B | 2.1B | 1.9B | 1.9B |
Tax provision | 336M | 406M | 371M | 460M |
Net income | 1.2B | 1.7B | 1.5B | 1.4B |
Basic EPS | 1.4 | 2.0 | 1.8 | 1.7 |
Diluted EPS | 1.4 | 2.0 | 1.8 | 1.7 |
Basic average shares | 850M | 854M | 855M | 856M |
Diluted average shares | 850M | 858M | 855M | 857M |
EBITDA | 2.6B | 3.8B | 2.9B | 2.8B |
Net income from continuing op. | 1.2B | 1.7B | 1.5B | 1.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |